Biotechnology | Disease | FDA | Therapeutics
FDA approved oral treatment for spinal muscular atrophy
On Aug. 7, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Evrysdi (risdiplam) to treat patients…
-
-
Biotechnology | COVID-19 | NIH
Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
-
City of Hope began CIRM-funded Coronavirus study
On Apr. 30, 2020, The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hopeﾒs John…
-
Stanford-led team developed privacy-focused coronavirus alert app
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
-
Harvard, MIT and Stanford commited to COVID-19 technology licensing principles, maximizing access to innovations
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
-
IGEA Pharma supplied COVID-19 antibody-based test in the US
On Apr. 6, 2020, IGEA Pharma announced that it was starting to supply of a COVID-19 antibody test…
-
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
-
UCSD researchers provided new insights into a key pathway that controls critical cell division mechanisms
On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…
-
Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
-
Genentech announced FDA approval of antiviral drug Xofluza (Baloxavir Marboxil)
On Oct. 17, 2019, Genentech announced the U.S. Food and Drug Administration (FDA) had approved Xofluza (Baloxavir Marboxil),…
-
deCODE in Iceland agreed to sequence half of UK Biobank participants, largest ever undertaken
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
-
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
-
deCODE published the first full resolution genetic map of the human genome
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
-
Disease | FDA | Therapeutics
Genentech drug Hemlibra (emicizumab-kxwh) was approved
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
-
Biotechnology | Environmental | Genomics | Life Science History | Medicine | Non-Profit Research | Pharmaceutical
Earth Microbiome Project scientists announced unprecedented catalog of microbial life on planet Earth
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
-
FDA approval brought first gene therapy to the U.S.
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
-
The Jackson Laboratory announced a National Institute on Drug Abuse five-year $11 million grant
On Aug. 8, 2016, the National Institute on Drug Abuse announced a five-year grant totaling $11,714,623 to The…
-
The Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded
In 2016, the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded with a $1 billion…
-
Genentech drug Cotellic (cobimetinib) was approved
On Nov. 10, 2015, Genentech announed that its drug Cotellic (cobimetinib) was approved by the U.S. Food and…
-
The Kavli Foundation awarded $20 million to establish the Kavli Neural Systems Institute at The University of California, San Francisco
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Institute for Fundamental…
-
The Kavli Foundation awarded $20 million to establish the Kavli Neuroscience Discovery Institute at The Johns Hopkins University
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neuroscience Discovery…
-
First-ever octopus genome sequenced
On Aug. 12, 2015, the Cephalopod Sequencing Consortium announced the first-ever sequencing of the entire octopus genome. Researchers…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
CDC’s Health Alert Network issued health advisory about multi-state outbreak of measles linked to Disneyland
On Jan. 23, 2015, the U.S. Centers for Disease Control and Prevention (CDC) Health Alert Network issued a…
-
Albert Einstein Cancer Center became site for the Hispanic Community Health Study
On Jan. 12, 2015, The Albert Einstein Cancer Center became the only medical institution in New York City,…
-
Agriculture | Biotechnology | Chemistry | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics | Veterinary
California Life Sciences Association was founded
In 2015, the California Life Sciences Association was founded. (CLSA) was founded when the Bay Area Bioscience Association…
-
Genentech drug Esbriet (pirfenidone) was approved
On Oct. 15, 2014, Genentech drug Esbriet (pirfenidone) was approved by the U.S. Food and Drug Administration (FDA)…
-
Amgen announced closure of former Boulder-based Synergen LakeCentre facility
On Jul. 29, 2014, Amgen announced closure of former Boulder-based Synergen LakeCentre facility. Amgen acquired Boulder-based Synergen in…
-
Biotechnology | FDA | Oncology | Therapeutics
Genentech drug Gazyva (obinutuzumab) was approved
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
-
Richard Scheller won Lasker Award
On Sept. 9, 2013 Genentech announced that Richard Scheller, Ph.D., Executive VP, Research and Early Development, was a…
